Key Market Highlights The global GLP-1 analogues market was valued at US$ 51.6 Billion in 2024 The market is expected to reach US$ 211.8 Billion by 2035 The industry is forecast to expand at a CAGR of 13.7% during 2025-2035 North America accounted for the largest market share of 68.4% in 2024 The Subcutaneous route of administration segment held 78.2% market share in 2024 Major industry participants include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and AstraZeneca Rising Type 2 Diabetes Cases Accelerating Market Growth The growing prevalence of type 2 diabetes remains one of the most significant growth drivers for the GLP-1 analogues market
1721/22, Ram Gali, Bhagirath Palace, Chandni Chowk, Delhi, Delhi, 110006, India vitamin b complex injections in Delhi Report incorrect details
Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials[J]
But avoid carrying interest-bearing balances, as financing costs can add 15 to 30 percent to your medication expenses over time
Inspections have teeth
Companies like The Vitamin Shoppe and Jamieson Wellness are taking advantage of the new customer base with lines of GLP-1 support products